Institution · Oncological Dispensary No. 2

Most cited papers from Oncological Dispensary No. 2

Oncological Dispensary No. 2

What are the most cited papers from Oncological Dispensary No. 2?

The most cited paper from Oncological Dispensary No. 2 is "A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer" (Rebecca Sophie Kristeleit, Ірина Давиденко, Vadim Shirinkin et al., 2017), with 102 citations. Next come "Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy" (81) and "Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinoma" (45).

Published TypeFieldAccess

Showing 50 of 75 papers. Every paper with more than 0 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer Rebecca Sophie Kristeleit, Ірина Давиденко, Vadim Shirinkin et al. · Gynecologic Oncology Open access	8 Jul 2017	102
2	Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy Kimberly Blackwell, Vladimir Semiglazov, Dmitriy Krasnozhon et al. · Annals of Oncology Open access	30 Jun 2015	81
3	Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinoma DAVID J. PROPPER, Ірина Давиденко, John A. Bridgewater et al. · Annals of Oncology Open access	15 May 2014	45
4	Different types of tumor vessels in breast cancer: morphology and clinical value M. A. Senchukova, Natalia V. Nikitenko, Olesia N. Tomchuk et al. · SpringerPlus Open access	17 Sep 2015	44
5	Randomized, Double-Blind Study Comparing Proposed Biosimilar La-Ep2006 with Reference Pegfilgrastim in Breast Cancer Nadia Harbeck, Oleg Nikolaevich Lipatov, Мона Александровна Фролова et al. · Future Oncology Open access	29 Mar 2016	38
6	Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial Ana Oaknin et al. · European Journal of Cancer	10 Jan 2025	27
7	Intraoperative radiotherapy as an immediate adjuvant treatment of rectal cancer due to limited access to external-beam radiotherapy Sergey Potemin, Jens Kübler, И. Б. Уваров et al. · Radiation Oncology Open access	10 Jan 2020	15
8	Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice Anna Turkina, N.V. Novitskaya, А. К. Голенков et al. · Clinical oncohematology Open access	Jul 2017	15
9	Key Results of International Randomized Open-Label Clinical Study of BCD-020 (rituximab biosimilar candidate) in Patients with B-Cell Non-Hodgkin’s Lymphoma Kamil’ Daniyalovich Kaplanov et al. · Blood	6 Dec 2014	12
10	Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials Michael Sticherling, Arjen Nikkels, Ashraf M. Hamza et al. · American Journal of Clinical Dermatology Open access	21 Jun 2023	10
11	Final Results of Phase II Trial (MIRACULUM) of the Novel PD-1 Inhibitor Prolgolimab in Patients with Advanced Melanoma Sergei Tjulandin, Mikhail Yu. Fedyanin, Лев Вадимович Демидов et al. · Annals of Oncology Open access	Dec 2019	9
12	Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation Liudmila Odnopozova, Anton Edin, А. Е. Сухарев et al. · Dermatology and Therapy Open access	2 Aug 2022	8
13	Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study Igor V Samoylenko et al. · Journal of Modern Oncology Open access	10 Dec 2023	7
14	Patient routing and process approach implementation for regional oncology service Roman A. Murashko, С. Н. Алексеенко, А. А. Кошкаров et al. · Кубанский научный медицинский вестник Open access	13 Feb 2021	7
15	RECONSTRUCTION OF POSTOPERATIVE DEFECTS AFTER REMOVAL OF HYPOPHARYNGEAL AND CERVICAL ESOPHAGEAL TUMORS T. V. Ostrinskaya, А. М. Жуманкулов, А. В. Анисимова · Head and neck tumors (HNT) Open access	8 Nov 2017	7
16	Updated Efficacy, Biomarker, and Exposure-Response Data from a Phase 2 Study of Rilotumumab (R) Plus Epirubicin, Cisplatin, and Capecitabine (ECX) in Gastric (G) or Esophagogastric Junction (EGJ) Cancer Ірина Давиденко, Timothy J. Iveson, Ross C. Donehower et al. · Annals of Oncology Open access	Sep 2012	6
17	A phase III study to access the safety and efficacy of prolgolimab 250 mg fixed dose administered every 3 weeks versus prolgolimab 1 mg/kg every 2 weeks in patients with metastatic melanoma (FLAT) Лев Вадимович Демидов et al. · Frontiers in Oncology Open access	4 Sep 2024	5
18	Selective opioid agonist Taphalgin® as a component of postoperative analgesia in various surgical areas: “NIKITA” observational multicenter study Aleksei E. Karelov et al. · Head and neck tumors (HNT) Open access	3 Aug 2024	5
19	Changes in the content of protein markers referring to the nervous tissue damage in patients with psychoactive substance dependence syndrome И. М. Быков, Konstantin Andreevich Popov, Dmitry Lubchenko et al. · Medical news of the North Caucasus Open access	2021	5
20	Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial Лев Вадимович Демидов et al. · European Journal of Cancer	5 Aug 2025	4
21	Self-Destructive Dermatosis Mimicking Pyoderma Gangrenosum: A Clinical Case Marina M. Tlish, М. И. Глузмин, Н. Л. Сычева et al. · Кубанский научный медицинский вестник Open access	10 Dec 2022	4
22	Neoadjuvant chemoradiotherapy for locally advanced rectal cancer with peritumoral abscesses and fistulas Sergey S. Gordeyev, Валерий Анатольевич Иванов, Mikhail Fedianin et al. · Strahlentherapie und Onkologie	25 Nov 2021	4
23	The functional outcomes of open vertical resections of the larynx А. L. Kozhanov, Л. Г. Кожанов, А. М. Сдвижков et al. · Russian Bulletin of Otorhinolaryngology	2019	4
24	Human papillomavirus-associated oropharyngeal carcinoma: trends in epidemiology and methods for detecting the virus in tumors А. I. Stukan, O. Yu. Chukhray, Vladimir Alekseyevich Porkhanov et al. · Head and neck tumors (HNT) Open access	7 Nov 2018	4
25	IMMEDIATE AND LONG-TERM OUTCOMES OF DRUG TREATMENT IN PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER O. V. Smirmova, Vasilii I. Borisov, Gelena P. Guens · Malignant tumours Open access	13 Nov 2018	4
26	INFECTIOUS ENDOCARDITIS CAUSED BY A RARE AGENT BURKHOLDERIA CEPACIAN Н. С. Чипигина, N. Yu. Karpova, N. P. Leontieva et al. · The Russian Archives of Internal Medicine Open access	12 Aug 2018	4
27	Efficacy and safety of netakimab therapy in patients with moderate to severe psoriasis in real clinical practice Andrey L. Bakulev, Olga A. Pritulo, Zhanna S. Kuntsevich et al. · Vestnik dermatologii i venerologii Open access	16 Nov 2023	3
28	Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study Tatyana N. Sokolova et al. · Journal of Modern Oncology Open access	30 Apr 2022	3
29	The role of a teacher-mentor in the modern world. Svetlana N. Kochkina · Pedagogy history prospects Open access	29 Apr 2020	3
30	Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia В. А. Горбунова et al. · Journal of Modern Oncology Open access	15 Mar 2019	3
31	EXTRALEVATOR ABDOMINOPERINEAL EXCISION OF THE RECTUM: SHORT-TERM OUTCOMES IN COMPARISON WITH CONVENTIONAL SURGERY Roman A. Murashko, И. Б. Уваров, Е. А. Ермаков et al. · Koloproktologia Open access	30 Dec 2017	3
32	Separation and identification of phenothiazine compounds by thin-layer chromatography З. А. Темердашев, Н. В. Киселева, Р. А. Клищенко et al. · Journal of Analytical Chemistry	2006	3
33	Changes in urine metabolite concentration as a minimally invasive marker of ovarian serous adenocarcinoma O.N. Guskova, I. A. Alliluev, Ekaterina V. Verenikina et al. · Russian Journal of Biotherapy Open access	18 Oct 2023	2
34	Clinical features of the course of tuberculous meningitis in HIV-infected patients Irina Yu. Babaeva, Andrey I. Shevchenko, Diana V. Dudchenko et al. · Consilium Medicum Open access	14 Oct 2023	2
35	Multicenter Randomized Controlled (Comparative) Open Prospective Study to Evaluate The Efficacy of The R-DA-EPOCH-21 And R-mNHL-BFM-90 ± Autologous Hematopoietic Stem Cell Transplantation Programs in Untreated Patients With De Novo Diffuse B-Cell Large Cell Lymphoma With Signs of Poor Prognosis - DLBCL-2015 Protocol Aminat Umaraskhabovna Magomedova et al. · Archives of Clinical Trials Open access	30 Nov 2022	2
36	Germinal BRCA-mutation significance in the tumor microenvironment formation Efficacy of PARP inhibition in late-line therapy of metastatic castration-resistant prostate cancer А. I. Stukan, А. Yu. Goryainova, N. A. Riger et al. · Cancer Urology Open access	10 Nov 2021	2
37	IMMEDIATE RESULTS OF LUNG RESECTIONS IN PATIENTS WITH FIBROUS CAVERNOUS TUBERCULOSIS D.E. Omelchuk, Д. В. Краснов, Т. И. Петренко et al. · Tuberculosis and lung diseases Open access	2019	2
38	Possibilities of using cryotherapy in patients with ocular rosacea Marina M. Tlish, N. V. Kolesnikova, Viktor Eduardovich Gyunter et al. · Ophthalmology Reports Open access	15 Dec 2018	2
39	TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA ACCORDING ON THE SPECIFIC MOLECULAR FEATURES OF THE TUMOR (A LITERATURE REVIEW) А. I. Stukan, R. A. Murashko, V. N. Bodnya et al. · Head and neck tumors (HNT) Open access	8 Nov 2017	2
40	ANGIOSARCOMA OF THE HEART – CLINICAL CASE N. Yu. Karpova, Moheb A. Rashid, Т. В. Казакова et al. · Rational Pharmacotherapy in Cardiology Open access	2017	2
41	Evaluation of Effectiveness and Safety of a New Short-Course Chemotherapy Regimen for Drug-Susceptible Tuberculosis V. V. Testov, I. A. Vasilyeva, V. A. Guseva et al. · Tuberculosis and lung diseases Open access	10 Jan 2026	1
42	Adjuvant targeted therapy in patients with skin melanoma: evidence from Russian real-world clinical practice (RATIONALE study) Igor V. Samoylenko et al. · Journal of Modern Oncology Open access	5 Dec 2025	1
43	Intermediate results of the PERFECTION observational study in a population of patients with metastatic, persistent and recurrent cervical cancer В. В. Саевец et al. · Journal of Modern Oncology Open access	17 Jul 2025	1
44	Modern antidepressants: a comparative analysis of efficacy and safety, prospects for studying new drugs Tatiana A. Pavlova, Marina A. Telepina, Vladimir V. Perelygin et al. · Pharmacy Formulas Open access	4 Aug 2025	1
45	Mental health protection in the primary health care: medico-social effectiveness Н. Г. Незнанов, V. B. Dutov, Vadim Sergeevich Skripov et al. · Russian Journal of Preventive Medicine	23 Apr 2024	1
46	Chemoradiotherapy of squamous cell anal cancer Karina S. Elizbaryan, Alexander F. Lazarev, Ya. N Shoykhet et al. · Russian Journal of Oncology Open access	15 Feb 2015	1
47	Socio-demographic and clinical-psychological characteristics of patients with residual schizophrenia and directions of their psychosocial rehabilitation Tatyana Anatolievna Solokhina, D. S. Oshevsky, M. V. Kuzminova et al. · S S Korsakov Journal of Neurology and Psychiatry Open access	23 Nov 2023	1
48	Analysis of the regional clinical use of CDK4/6 inhibitor ribociclib as a mechanism of integration of a research approach in drug provision А. Yu. Goryainova, R. A. Murashko, S. V. Sharov et al. · Meditsinskiy sovet = Medical Council Open access	29 Jul 2023	1
49	C-POST Protocol Update: A Phase 3, Randomized, Double-Blind Study of Adjuvant Cemiplimab vs. Placebo Post Surgery and Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell Carcinoma Danny Rischin, D. Brungs, F. Day et al. · International Journal of Radiation OncologyBiologyPhysics	22 Oct 2022	1
50	Evolution of the CDK4/6 inhibitor abemaciclib: from palliative to adjuvant therapy. Clinical experience with abemaciclib in patients with hormone-receptor-positive, HER2-negative breast cancer А. Yu. Goryainova, А. I. Stukan, R. A. Murashko et al. · Meditsinskiy sovet = Medical Council Open access	18 Jun 2022	1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.